Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Matthew Caufield's Stock Ratings
HC Wainwright & Co. Analyst
Matthew Caufield is an analyst at HC Wainwright & Co.. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/25/2025
Overall Average Return
-32.8%
Smart Score
Overall Average Return Percentile
7th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/23/2025 | UBX | Buy Now | Unity Biotechnology | $1.00 | 300% | Matthew Caufield36% | $4 → $4 | Reiterates | Buy → Buy | Get Alert |
| 04/16/2025 | LENZ | Buy Now | LENZ Therapeutics | $28.61 | 32.82% | Matthew Caufield36% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 04/16/2025 | ADVM | Buy Now | Adverum Biotechnologies | $2.83 | 961.95% | Matthew Caufield36% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 04/15/2025 | IMUX | Buy Now | Immunic | $1.18 | 747.46% | Matthew Caufield36% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 04/04/2025 | ALDX | Buy Now | Aldeyra Therapeutics | $2.64 | 278.79% | Matthew Caufield36% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 04/02/2025 | MLYS | Buy Now | Mineralys Therapeutics | $13.27 | 216.62% | Matthew Caufield36% | $30 → $42 | Maintains | Buy | Get Alert |
| 04/02/2025 | SRZN | Buy Now | Surrozen | $9.66 | 231.26% | Matthew Caufield36% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
| 04/01/2025 | FBLG | Buy Now | FibroBiologics | $1.21 | 895.85% | Matthew Caufield36% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 04/01/2025 | IRD | Buy Now | Opus Genetics | $0.80 | 900% | Matthew Caufield36% | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
| 03/31/2025 | HLVX | Buy Now | HilleVax | $1.83 | 8.99% | Matthew Caufield36% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
| 03/31/2025 | KOD | Buy Now | Kodiak Sciences | $4.05 | -25.93% | Matthew Caufield36% | $3 → $3 | Reiterates | Neutral → Neutral | Get Alert |
| 03/25/2025 | OPT | Buy Now | Opthea | $3.31 | -39.58% | Matthew Caufield36% | $12 → $2 | Downgrade | Buy → Neutral | Get Alert |
| 03/25/2025 | UBX | Buy Now | Unity Biotechnology | $1.00 | 300% | Matthew Caufield36% | $8 → $4 | Maintains | Buy | Get Alert |
| 03/24/2025 | UBX | Buy Now | Unity Biotechnology | $1.00 | 300% | Matthew Caufield36% | $8 → $4 | Maintains | Buy | Get Alert |
| 03/21/2025 | EYEN | Buy Now | Eyenovia | $1.09 | 83.49% | Matthew Caufield36% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
| 03/21/2025 | OPTN | Buy Now | OptiNose | $9.28 | -3.02% | Matthew Caufield36% | $18 → $9 | Downgrade | Buy → Neutral | Get Alert |
| 03/19/2025 | DMAC | Buy Now | DiaMedica Therapeutics | $4.03 | 148.45% | Matthew Caufield36% | $7 → $10 | Maintains | Buy | Get Alert |
| 03/14/2025 | LYRA | Buy Now | Lyra Therapeutics | $0.10 | 1876.28% | Matthew Caufield36% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
| 03/12/2025 | ZBIO | Buy Now | Zenas BioPharma | $10.19 | 194.55% | Matthew Caufield36% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 03/10/2025 | MLYS | Buy Now | Mineralys Therapeutics | $13.27 | 126.16% | Matthew Caufield36% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 03/10/2025 | UBX | Buy Now | Unity Biotechnology | $1.00 | 700% | Matthew Caufield36% | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
| 03/07/2025 | PHAT | Buy Now | Phathom Pharmaceuticals | $4.12 | 579.61% | Matthew Caufield36% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 03/03/2025 | ALDX | Buy Now | Aldeyra Therapeutics | $2.64 | 278.79% | Matthew Caufield36% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 03/03/2025 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.32 | 984.34% | Matthew Caufield36% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
| 02/28/2025 | OPT | Buy Now | Opthea | $3.31 | 262.54% | Matthew Caufield36% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 02/21/2025 | IMUX | Buy Now | Immunic | $1.18 | 747.46% | Matthew Caufield36% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 02/19/2025 | IRD | Buy Now | Opus Genetics | $0.80 | 900% | Matthew Caufield36% | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
| 02/13/2025 | MLYS | Buy Now | Mineralys Therapeutics | $13.27 | 126.16% | Matthew Caufield36% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 02/13/2025 | FBLG | Buy Now | FibroBiologics | $1.21 | 895.85% | Matthew Caufield36% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 02/10/2025 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.32 | 984.34% | Matthew Caufield36% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
| 02/06/2025 | EYEN | Buy Now | Eyenovia | $1.09 | 83.49% | Matthew Caufield36% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
| 01/30/2025 | SRZN | Buy Now | Surrozen | $9.66 | 231.26% | Matthew Caufield36% | → $32 | Initiates | → Buy | Get Alert |
| 01/29/2025 | OPT | Buy Now | Opthea | $3.31 | 262.54% | Matthew Caufield36% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 01/13/2025 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.32 | 984.34% | Matthew Caufield36% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
| 01/03/2025 | OPTN | Buy Now | OptiNose | $9.28 | 93.97% | Matthew Caufield36% | $5 → $18 | Maintains | Buy | Get Alert |
| 12/16/2024 | ZBIO | Buy Now | Zenas BioPharma | $10.19 | 194.55% | Matthew Caufield36% | → $30 | Initiates | → Buy | Get Alert |
| 12/12/2024 | PHAT | Buy Now | Phathom Pharmaceuticals | $4.12 | 579.61% | Matthew Caufield36% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 12/12/2024 | IRD | Buy Now | Opus Genetics | $0.80 | 900% | Matthew Caufield36% | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
| 11/25/2024 | IMUX | Buy Now | Immunic | $1.18 | 747.46% | Matthew Caufield36% | → $10 | Initiates | → Buy | Get Alert |
| 11/19/2024 | ADVM | Buy Now | Adverum Biotechnologies | $2.83 | 961.95% | Matthew Caufield36% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 11/18/2024 | EYEN | Buy Now | Eyenovia | $1.09 | 83.49% | Matthew Caufield36% | $960 → $160 | Downgrade | Buy → Neutral | Get Alert |
| 11/15/2024 | KOD | Buy Now | Kodiak Sciences | $4.05 | -25.93% | Matthew Caufield36% | $3 → $3 | Reiterates | Neutral → Neutral | Get Alert |
| 11/15/2024 | DMAC | Buy Now | DiaMedica Therapeutics | $4.03 | 73.91% | Matthew Caufield36% | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
| 11/14/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.32 | 984.34% | Matthew Caufield36% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2024 | FBLG | Buy Now | FibroBiologics | $1.21 | 895.85% | Matthew Caufield36% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2024 | EYEN | Buy Now | Eyenovia | $1.09 | 1000.92% | Matthew Caufield36% | $960 → $960 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2024 | OPTN | Buy Now | OptiNose | $9.28 | -46.12% | Matthew Caufield36% | $75 → $75 | Reiterates | Buy → Buy | Get Alert |
| 11/12/2024 | MLYS | Buy Now | Mineralys Therapeutics | $13.27 | 126.16% | Matthew Caufield36% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 11/07/2024 | LENZ | Buy Now | LENZ Therapeutics | $28.61 | 32.82% | Matthew Caufield36% | $38 → $38 | Reiterates | Buy → Buy | Get Alert |
| 10/31/2024 | MLYS | Buy Now | Mineralys Therapeutics | $13.27 | 126.16% | Matthew Caufield36% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 10/30/2024 | FBLG | Buy Now | FibroBiologics | $1.21 | 895.85% | Matthew Caufield36% | → $12 | Initiates | → Buy | Get Alert |
| 10/10/2024 | DMAC | Buy Now | DiaMedica Therapeutics | $4.03 | 73.91% | Matthew Caufield36% | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
| 10/07/2024 | DMAC | Buy Now | DiaMedica Therapeutics | $4.03 | 73.91% | Matthew Caufield36% | → $7 | Initiates | → Buy | Get Alert |
| 09/24/2024 | KOD | Buy Now | Kodiak Sciences | $4.05 | -25.93% | Matthew Caufield36% | $3 → $3 | Reiterates | Neutral → Neutral | Get Alert |
| 09/19/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.32 | 984.34% | Matthew Caufield36% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
| 09/05/2024 | KOD | Buy Now | Kodiak Sciences | $4.05 | -25.93% | Matthew Caufield36% | → $3 | Initiates | → Neutral | Get Alert |
| 09/03/2024 | OPT | Buy Now | Opthea | $3.31 | 262.54% | Matthew Caufield36% | $14 → $12 | Maintains | Buy | Get Alert |
| 08/15/2024 | LYRA | Buy Now | Lyra Therapeutics | $0.10 | 1876.28% | Matthew Caufield36% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
| 08/15/2024 | LENZ | Buy Now | LENZ Therapeutics | $28.61 | 32.82% | Matthew Caufield36% | $38 → $38 | Reiterates | Buy → Buy | Get Alert |
| 08/15/2024 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield36% | $20 → $18 | Maintains | Buy | Get Alert |
| 08/15/2024 | MLYS | Buy Now | Mineralys Therapeutics | $13.27 | 126.16% | Matthew Caufield36% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 08/13/2024 | ADVM | Buy Now | Adverum Biotechnologies | $2.83 | 961.95% | Matthew Caufield36% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 08/13/2024 | EYEN | Buy Now | Eyenovia | $1.09 | 1000.92% | Matthew Caufield36% | $960 → $960 | Reiterates | Buy → Buy | Get Alert |
| 08/12/2024 | HLVX | Buy Now | HilleVax | $1.83 | 8.99% | Matthew Caufield36% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
| 08/12/2024 | LENZ | Buy Now | LENZ Therapeutics | $28.61 | 32.82% | Matthew Caufield36% | → $38 | Initiates | → Buy | Get Alert |
| 08/12/2024 | PHAT | Buy Now | Phathom Pharmaceuticals | $4.12 | 579.61% | Matthew Caufield36% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.32 | 984.34% | Matthew Caufield36% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2024 | ALDX | Buy Now | Aldeyra Therapeutics | $2.64 | 278.79% | Matthew Caufield36% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 08/02/2024 | ALDX | Buy Now | Aldeyra Therapeutics | $2.64 | 278.79% | Matthew Caufield36% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 07/24/2024 | EYEN | Buy Now | Eyenovia | $1.09 | 1000.92% | Matthew Caufield36% | $960 → $960 | Reiterates | Buy → Buy | Get Alert |
| 07/19/2024 | PHAT | Buy Now | Phathom Pharmaceuticals | $4.12 | 579.61% | Matthew Caufield36% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 07/10/2024 | MLYS | Buy Now | Mineralys Therapeutics | $13.27 | 126.16% | Matthew Caufield36% | → $30 | Initiates | → Buy | Get Alert |
| 07/09/2024 | HLVX | Buy Now | HilleVax | $1.83 | — | Matthew Caufield36% | — | Downgrade | Buy → Neutral | Get Alert |
| 06/07/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.32 | 984.34% | Matthew Caufield36% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2024 | EYEN | Buy Now | Eyenovia | $1.09 | 1000.92% | Matthew Caufield36% | $960 → $960 | Reiterates | Buy → Buy | Get Alert |
| 05/15/2024 | OPTN | Buy Now | OptiNose | $9.28 | -46.12% | Matthew Caufield36% | $75 → $75 | Reiterates | Buy → Buy | Get Alert |
| 05/13/2024 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield36% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
| 05/13/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.32 | 984.34% | Matthew Caufield36% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
| 05/10/2024 | PHAT | Buy Now | Phathom Pharmaceuticals | $4.12 | 579.61% | Matthew Caufield36% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 05/10/2024 | HLVX | Buy Now | HilleVax | $1.83 | 1425.89% | Matthew Caufield36% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 05/10/2024 | ADVM | Buy Now | Adverum Biotechnologies | $2.83 | 961.95% | Matthew Caufield36% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 05/07/2024 | LYRA | Buy Now | Lyra Therapeutics | $0.10 | 1876.28% | Matthew Caufield36% | → $2 | Downgrade | Buy → Neutral | Get Alert |
| 05/06/2024 | ALDX | Buy Now | Aldeyra Therapeutics | $2.64 | 278.79% | Matthew Caufield36% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 05/01/2024 | LYRA | Buy Now | Lyra Therapeutics | $0.10 | 11757.71% | Matthew Caufield36% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 04/30/2024 | ADVM | Buy Now | Adverum Biotechnologies | $2.83 | 961.95% | Matthew Caufield36% | → $30 | Initiates | → Buy | Get Alert |
| 04/29/2024 | OPTN | Buy Now | OptiNose | $9.28 | -46.12% | Matthew Caufield36% | $75 → $75 | Reiterates | Buy → Buy | Get Alert |
| 04/02/2024 | ALDX | Buy Now | Aldeyra Therapeutics | $2.64 | 278.79% | Matthew Caufield36% | → $10 | Reinstates | Buy → Buy | Get Alert |
| 03/22/2024 | LYRA | Buy Now | Lyra Therapeutics | $0.10 | 11757.71% | Matthew Caufield36% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 03/21/2024 | HLVX | Buy Now | HilleVax | $1.83 | 1425.89% | Matthew Caufield36% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 03/19/2024 | EYEN | Buy Now | Eyenovia | $1.09 | 1000.92% | Matthew Caufield36% | $960 → $960 | Reiterates | Buy → Buy | Get Alert |
| 03/18/2024 | OPTN | Buy Now | OptiNose | $9.28 | -46.12% | Matthew Caufield36% | $75 → $75 | Reiterates | Buy → Buy | Get Alert |
| 03/11/2024 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield36% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
| 03/11/2024 | OPTN | Buy Now | OptiNose | $9.28 | -46.12% | Matthew Caufield36% | → $75 | Initiates | → Buy | Get Alert |
| 03/08/2024 | PHAT | Buy Now | Phathom Pharmaceuticals | $4.12 | 579.61% | Matthew Caufield36% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 03/06/2024 | EYEN | Buy Now | Eyenovia | $1.09 | 1000.92% | Matthew Caufield36% | $960 → $960 | Reiterates | Buy → Buy | Get Alert |
| 03/01/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.32 | 984.34% | Matthew Caufield36% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
| 12/13/2023 | HLVX | Buy Now | HilleVax | $1.83 | 1425.89% | Matthew Caufield36% | → $28 | Initiates | → Buy | Get Alert |
| 11/14/2023 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield36% | → $20 | Reiterates | Buy → Buy | Get Alert |
| 11/14/2023 | UBX | Buy Now | Unity Biotechnology | $1.00 | 900% | Matthew Caufield36% | → $10 | Reiterates | Buy → Buy | Get Alert |
| 11/14/2023 | EYEN | Buy Now | Eyenovia | $1.09 | 1000.92% | Matthew Caufield36% | → $960 | Reiterates | Buy → Buy | Get Alert |
| 10/02/2023 | LYRA | Buy Now | Lyra Therapeutics | $0.10 | 11757.71% | Matthew Caufield36% | → $12 | Reiterates | Buy → Buy | Get Alert |
| 08/31/2023 | LYRA | Buy Now | Lyra Therapeutics | $0.10 | 11757.71% | Matthew Caufield36% | → $12 | Initiates | → Buy | Get Alert |
| 08/22/2023 | FN | Buy Now | Fabrinet | $201.15 | -86.08% | Matthew Caufield36% | → $28 | Reiterates | Buy → Buy | Get Alert |
| 08/18/2023 | EYEN | Buy Now | Eyenovia | $1.09 | 1000.92% | Matthew Caufield36% | → $960 | Reiterates | Buy → Buy | Get Alert |
| 08/14/2023 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield36% | → $20 | Reiterates | Buy → Buy | Get Alert |
| 08/11/2023 | PHAT | Buy Now | Phathom Pharmaceuticals | $4.12 | 579.61% | Matthew Caufield36% | → $28 | Reiterates | Buy → Buy | Get Alert |
| 08/11/2023 | EYEN | Buy Now | Eyenovia | $1.09 | 1000.92% | Matthew Caufield36% | → $960 | Reiterates | Buy → Buy | Get Alert |
| 08/10/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.32 | 984.34% | Matthew Caufield36% | → $36 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2023 | PHAT | Buy Now | Phathom Pharmaceuticals | $4.12 | 579.61% | Matthew Caufield36% | → $28 | Initiates | → Buy | Get Alert |
| 08/09/2023 | UBX | Buy Now | Unity Biotechnology | $1.00 | 900% | Matthew Caufield36% | → $10 | Reiterates | Buy → Buy | Get Alert |
| 08/01/2023 | OPT | Buy Now | Opthea | $3.31 | 322.96% | Matthew Caufield36% | → $14 | Reiterates | Buy → Buy | Get Alert |
| 07/31/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.32 | 984.34% | Matthew Caufield36% | → $36 | Reiterates | Buy → Buy | Get Alert |
| 06/30/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $2.64 | 468.18% | Matthew Caufield36% | → $15 | Reiterates | Buy → Buy | Get Alert |
| 06/22/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $2.64 | 468.18% | Matthew Caufield36% | → $15 | Reiterates | Buy → Buy | Get Alert |
| 06/16/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $2.64 | 468.18% | Matthew Caufield36% | → $15 | Reiterates | Buy → Buy | Get Alert |
| 06/08/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.32 | 984.34% | Matthew Caufield36% | → $36 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2023 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield36% | → $20 | Reiterates | Buy → Buy | Get Alert |
| 05/12/2023 | EYEN | Buy Now | Eyenovia | $1.09 | 1000.92% | Matthew Caufield36% | → $960 | Reiterates | Buy → Buy | Get Alert |
| 05/11/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.32 | 984.34% | Matthew Caufield36% | → $36 | Reiterates | Buy → Buy | Get Alert |
| 05/10/2023 | UBX | Buy Now | Unity Biotechnology | $1.00 | 900% | Matthew Caufield36% | → $10 | Reiterates | → Buy | Get Alert |
| 05/05/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $2.64 | 468.18% | Matthew Caufield36% | → $15 | Reiterates | → Buy | Get Alert |
| 05/02/2023 | ISEE | Buy Now | IVERIC bio | — | — | Matthew Caufield36% | $35 → $40 | Downgrade | Buy → Neutral | Get Alert |
| 04/28/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.32 | 984.34% | Matthew Caufield36% | → $36 | Reiterates | → Buy | Get Alert |
| 04/19/2023 | EYEN | Buy Now | Eyenovia | $1.09 | 1000.92% | Matthew Caufield36% | → $960 | Reiterates | → Buy | Get Alert |
| 04/03/2023 | EYEN | Buy Now | Eyenovia | $1.09 | 1000.92% | Matthew Caufield36% | → $960 | Reiterates | → Buy | Get Alert |
| 03/31/2023 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield36% | → $20 | Reiterates | → Buy | Get Alert |
| 03/28/2023 | UBX | Buy Now | Unity Biotechnology | $1.00 | 900% | Matthew Caufield36% | → $10 | Reiterates | → Buy | Get Alert |
| 03/16/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.32 | 984.34% | Matthew Caufield36% | → $36 | Reiterates | → Buy | Get Alert |
| 03/10/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $2.64 | 468.18% | Matthew Caufield36% | → $15 | Reiterates | → Buy | Get Alert |
| 03/02/2023 | ISEE | Buy Now | IVERIC bio | — | — | Matthew Caufield36% | → $35 | Reiterates | → Buy | Get Alert |
| 03/01/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $2.64 | 468.18% | Matthew Caufield36% | → $15 | Reiterates | → Buy | Get Alert |
| 02/24/2023 | OPT | Buy Now | Opthea | $3.31 | 322.96% | Matthew Caufield36% | → $14 | Reiterates | → Buy | Get Alert |
| 02/23/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.32 | 984.34% | Matthew Caufield36% | → $36 | Reiterates | → Buy | Get Alert |
| 02/17/2023 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield36% | → $20 | Reiterates | → Buy | Get Alert |
| 02/17/2023 | ISEE | Buy Now | IVERIC bio | — | — | Matthew Caufield36% | → $35 | Reiterates | → Buy | Get Alert |
| 02/06/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.32 | 984.34% | Matthew Caufield36% | → $36 | Reiterates | → Buy | Get Alert |
| 01/26/2023 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield36% | $26 → $20 | Maintains | Buy | Get Alert |
| 12/08/2022 | OPT | Buy Now | Opthea | $3.31 | 322.96% | Matthew Caufield36% | → $14 | Initiates | → Buy | Get Alert |
| 11/18/2022 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.32 | 984.34% | Matthew Caufield36% | → $36 | Initiates | → Buy | Get Alert |
| 11/04/2022 | ISEE | Buy Now | IVERIC bio | — | — | Matthew Caufield36% | $26 → $35 | Maintains | Buy | Get Alert |
| 10/05/2022 | EYEN | Buy Now | Eyenovia | $1.09 | 1000.92% | Matthew Caufield36% | → $960 | Initiates | → Buy | Get Alert |
| 07/18/2022 | OYST | Buy Now | Oyster Point Pharma | — | — | Matthew Caufield36% | → $20 | Initiates | → Buy | Get Alert |
| 11/10/2021 | ISEE | Buy Now | IVERIC bio | — | — | Matthew Caufield36% | $20 → $26 | Maintains | Buy | Get Alert |
| 08/19/2021 | ISEE | Buy Now | IVERIC bio | — | — | Matthew Caufield36% | → $20 | Initiates | → Buy | Get Alert |
